95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.12%
Revenue growth at 50-75% of FNV's 45.39%. Martin Whitman would worry about competitiveness or product relevance.
25.66%
Gross profit growth at 50-75% of FNV's 41.39%. Martin Whitman would question if cost structure or brand is lagging.
24.79%
EBIT growth 50-75% of FNV's 37.27%. Martin Whitman would suspect suboptimal resource allocation.
24.79%
Operating income growth at 50-75% of FNV's 37.29%. Martin Whitman would doubt the firm’s ability to compete efficiently.
21.19%
Net income growth under 50% of FNV's 56.95%. Michael Burry would suspect the firm is falling well behind a key competitor.
20.00%
EPS growth under 50% of FNV's 50.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.53%
Diluted EPS growth at 50-75% of FNV's 44.44%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.10%
Share reduction more than 1.5x FNV's 4.11%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.01%
Diluted share reduction more than 1.5x FNV's 9.65%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.07%
Dividend reduction while FNV stands at 4.21%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
32.30%
Positive OCF growth while FNV is negative. John Neff would see this as a clear operational advantage vs. the competitor.
35.01%
Positive FCF growth while FNV is negative. John Neff would see a strong competitive edge in net cash generation.
145787334.37%
10Y revenue/share CAGR above 1.5x FNV's 113.98%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
152.10%
5Y revenue/share CAGR 1.25-1.5x FNV's 113.98%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
148.31%
3Y revenue/share CAGR 1.25-1.5x FNV's 113.98%. Bruce Berkowitz might see better product or regional expansions than the competitor.
47649.80%
10Y OCF/share CAGR above 1.5x FNV's 39.72%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
215.19%
5Y OCF/share CAGR above 1.5x FNV's 39.72%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
197.01%
3Y OCF/share CAGR above 1.5x FNV's 39.72%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
55639.64%
Net income/share CAGR above 1.5x FNV's 178.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
261.20%
5Y net income/share CAGR 1.25-1.5x FNV's 178.21%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
302.90%
3Y net income/share CAGR above 1.5x FNV's 178.21%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
153.14%
5Y equity/share CAGR above 1.5x FNV's 33.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
92.18%
3Y equity/share CAGR above 1.5x FNV's 33.01%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.48%
AR growth well above FNV's 8.73%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
1.82%
Asset growth above 1.5x FNV's 0.79%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.14%
Positive BV/share change while FNV is negative. John Neff sees a clear edge over a competitor losing equity.
-7.14%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
66.32%
SG&A growth well above FNV's 36.03%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.